| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | -0.00093 | 1 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.0008 | 1 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.00075 | 1 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.0009 | 1 |